Combination of Durvalumab and Tremelimumab as Maintenance Treatment in Patients With Non Squamous and Squamous (NSCLC)

Clinical trial NCT03319316 · WITHDRAWN

Trial details

NCT number: NCT03319316
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Squamous Non-small Cell Lung Cancer Non-Squamous Non-small Cell Lung Cancer

Start date: 2018-11-01
Primary completion: 2021-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.